🔬 Peptide Spotlight: Thymosin Alpha-1 (TA-1) You’ve probably seen Thymosin Alpha-1 mentioned in conversations about the immune system, inflammation and recovering from illness. But what exactly is it? 🧬 Thymosin Alpha-1—often shortened to TA-1 or Tα1—is a naturally occurring 28-amino-acid peptide involved in immune regulation. The manufactured version is called thymalfasin and has been sold under the brand name Zadaxin. Researchers have studied TA-1 in areas involving: • T-cell activity • Immune-system regulation • Inflammation • Vaccine response • Viral infections • Sepsis and critical illness • Support alongside certain cancer treatments One reason TA-1 gets so much attention is because researchers are studying how it may help regulate certain immune responses. That is different from simply “boosting” the immune system. More immune activity is not always better, and the condition being studied, the patient population and whether TA-1 was used alongside another treatment all matter. TA-1 also has an interesting legal and regulatory history. Thymalfasin has reportedly been approved or registered in more than 30 countries. Markets have included China, Italy, South Korea, Thailand, Singapore, Indonesia, Cambodia and Argentina. Its approved uses are not the same in every country. Depending on the location, it has been used for chronic hepatitis B or C, as a vaccine adjuvant or alongside certain cancer treatments. In the United States, however, there is currently no FDA-approved medication containing Thymosin Alpha-1. That does not mean TA-1 is simply “illegal” in the United States. It means the FDA has not approved a TA-1 product for a specific medical use, dose and manufacturing standard. You may still see TA-1 offered by compounding pharmacies, wellness clinics or research companies, but availability is not the same thing as FDA approval. You may also hear TA-1 described online as an “immune-system reset” or something that will prevent you from getting sick.